AzTrials
AzTrials

Muscle DamageNCT01555775

Compared Effect of a Fruit Milk Shake With a Protein-Carbohydrate Supplement on Recovery After Resistance Exercise

A study testing P-CHO supplement and Fruit Milk Shake in people with Muscle Damage and Inflammation, run by Universidade do Porto at 1 site in Portugal.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study is to assess the effect of ingesting a commercial carbohydrate and protein dietary supplement in powder form (P-CHO supplement) or a milk shake with skimmed milk, strawberries and banana (MS), after resistance exercise, in muscle damage, oxidative stress, inflammation and functional recovery. Read more about this study

Who is it for?
Ages 18 years and older, men onlyHealthy volunteers can take part
Conditions the study is for
Muscle Damage, Inflammation, Oxidative Stress
What is being tested?
P-CHO supplement and Fruit Milk Shake
Could I receive a placebo?
No, everyone receives an active treatment
How many people
13 participants
Where
1 sitePortugal
Study dates
Mar 2012to May 2012
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Men only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • healthy and lactose tolerant

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country.

Portugal1 site
  • Faculdade de Desporto, Universidade do Porto

    Porto, 4200-450

Other trials in Portugal

About this study

Official title: Compared Effect of a Fruit Milk Shake With a Protein-Carbohydrate Supplement on Muscle Damage, Inflammation, Oxidative Stress and Functional Recovery, After Resistance Exercise

The aim of this study is to assess the effect of ingesting a commercial carbohydrate and protein dietary supplement in powder form (P-CHO supplement) or a milk shake with skimmed milk, strawberries and banana (MS), after resistance exercise, in muscle damage, oxidative stress, inflammation and functional recovery. It is hypothesised if the ingestion of a milk shake with skimmed milk and fruit (strawberry and banana) has the same impact on markers of muscle damage, oxidative stress, inflammation and functional recovery induced by resistance exercise, as the intake of a commercial powder with the same CHO and protein amounts.

Fifteen adult athletes from the Portuguese Athletic Federation will complete 2 trials separated at least by 2 weeks. Alternate legs and drinks will be used in each trial and participants will be overnight-fasted. This study will have a single-blind, randomized, crossover, repeated-measures experimental design. In each trial, after warm-up, the eccentric peak torque of the knee joint extensors will be determined using an isokinetic dynamometer. After this, participants will complete an isokinetic exercise until exhaustion at a constant angular velocity of 60° • s-1. After the exhaustion protocol, athletes will perform again the peak torque determination. Immediately after, participants will drink the P-CHO supplement or MS during the first 2 h. Both drinks will contain 0.8-1.2 g carbohydrates • kg-1 • h-1 and 0.2-0.4 g protein • kg-1 • h-1. Twenty four and 48 h after the exhaustion protocol participants will return to the laboratory to repeat the peak torque determination. Blood samples will be collected before warming-up, immediately and 2 h after the last peak torque determination and 24 h and 48 h after. Serum samples will be analyzed for creatine kinase, lactate dehydrogenase, interleukine-6, protein carbonyls and total antioxidant status. The delayed onset muscle soreness, using a visual analogue scale, and girths will be measured at the same moments as blood sampling. Two-way repeated-measures ANOVA will be used for statistical analysis of the data.

Read the detailed description

Sample:

Fifteen adult athletes from the Portuguese Athletic Federation will be invited to participate in this study. They must be healthy and lactose tolerant. Athletes will be voluntary and should receive an explanatory document with the aims of the study. They must also sign an informed consent to participate. To help ensuring that the metabolic conditions are similar between trials, subjects will be instructed to fulfill a food record and a physical activity record of the 2 days prior to each trial (Shirreffs, Watson, \& Maughan, 2007). It will be asked not to make drastic changes in diet and to avoid strenuous exercise during this period.

Experimental Protocol:

This study will have a single-blind, randomized, crossover, repeated-measures experimental design. As shown in Figure 1, each participant should complete 2 trials, with a wash out period of, at least, 2 weeks. In one trial subjects will randomly drink the P-CHO supplement and in the other, the MS. In order to minimize any repeated bout effect, different legs will be used in each trial (Howatson et al., 2010).

About one week before the exercise protocol, participants will be familiarized with the experimental procedures and measurements. At this time, anthropometric assessments (BW, height and body fat percentage) will also be taken.

All tests should be performed in the morning, in a fasted state. At the beginning of each trial, the participants will warm-up for 5 min using a cycle ergometer at an intensity of 70-100 rpm. After the warm-up, the eccentric peak torque of the knee joint extensors muscles will be determined by isokinetic dynamometry (Biodex®, system IV). Then, the participants will complete concentric/eccentric knee extension/flexion exercise protocol until exhaustion. After exhaustion, eccentric peak torque determination will be repeated. Immediately after finishing the isokinetic test, participants will drink the P-CHO supplement or MS during the first 2 hours post-exercise. The drinks will be taken in 2 bolus per hour, during 2 h. During the 2 days after the exhaustion protocol (24 h and 48 h after), participants will return to the laboratory to repeat eccentric peak torque determination after a similar warm-up of the day before.

Drinks' Composition:

The nutritional formula of both drinks will be equal in terms of CHO and protein content in order to achieve the recommendation values of 0.8-1.2 g CHO • kg-1 BW • h-1 and 0.2-0.4 g protein • kg-1 BW • h-1 (Beelen et al 2010). They will also have similar amounts of vitamin C.

The fruit content of the MS will be 100 g of strawberry and the amount of banana necessary to guaranty 0.8-1.2 g CHO • kg-1 BW • h-1. Regarding the P-CHO supplement, it has to be available in a common local market and meet the recommend amounts of CHO and protein for the recovery period. If necessary, vitamin C will be added to match the MS content.

Exhaustion Protocol:

For inducting exhaustion, a concentric/eccentric knee extension/flexion exercise until exhaustion will be used. At the first day of each trial, the exhaustion protocol will be conducted. Securely fastened into the test chair of the isokinetic dynamometer with the knee joint of the test limb aligned with the axis of rotation of the dynamometer and the distal lower limb secured to the dynamometer's test arm, subjects will initially complete 3 maximal repetitions of knee joint extension and flexion at a constant angular velocity of 60°•s-1 to determine the subject's maximal peak torque of the knee extensors muscles (the best of the 3 repetitions). After this, the exhaustion protocol it will be conducted. The protocol will consist of 3 bouts of a concentric/eccentric knee extension/flexion exercise, at 60°•s-1, with a 200-second rest time between sets. The first and second set will be composed by 100 repetitions; in the third set, subjects will perform n repetitions until the eccentric peak value of 3 consecutive repetitions fell below 25% of the initial knee extensor eccentric peak torque value. The range of motion will be from 50° to 110° flexion in the knee (0º = full knee extension).

Participants will receive verbal encouragement to perform maximally throughout the exercise protocol.

Functional Recovery:

To monitor force recovery, measures of eccentric peak torque of the knee joint extensor muscles will be determined. Athletes will perform the isokinetic strength tests immediately before and after the exhaustion protocol and 24 and 48 h after the exhaustion protocol, for each trial. The exercise will consist of 3 maximal repetitions to determine eccentric knee joint extension peak torque at a constant angular velocity of 60°•s-1. The range of motion will be similar to the one used in the exhaustion protocol.

Blood Sampling and Biomarkers:

For each trial, blood will be taken from an antecubital vein after the participant arrives at the laboratory, in a fasted state. Blood samples will also be collected immediately after the last peak torque determination and 2, 24 and 48 h after.

The following blood markers will be used:

  • Muscle damage: CK and LDH;
  • Inflammation: IL-6;
  • Oxidative stress: protein carbonyls and TAS.

Other Measurements:

The DOMS and circumferential measurements will be measured at the same moments as blood sampling.

A visual analogue scale (VAS), 10 cm in length, will be used to determine DOMS (Bijur, Silver, \& Gallagher, 2001).

The mid-thigh girth measurement will be done according to the anthropometric technique suggested by the International Society for the Advancement of Kinanthropometry (ISAK). Three other girths will be measured: 5, 15 and 25 cm above the superior border of the patella. These measurements will allow monitoring the oedema caused by inflammation.

Body Composition:

Weight and height will be measured according to the methodology proposed by the International Society for the ISAK. It will be calculated the body mass index (BMI) and the percentage of body fat by measuring four skinfolds (biceps, triceps, subscapular and suprailiac) according to the technique proposed by ISAK. The value of the measurements will be converted to body density and using the formula: Durnin and Womersley 1974 (Costa, 2001). Later, the body density value will be converted to percentage of body mass, using the formula of Siri (Costa, 2001).

Dietary Intake:

Athletes will be asked to carry out food records 2 days prior to each trial. Each individual will be informed both orally and in writing, by an expert nutritionist, on their correct completion. It also will be required to register the time and place where food consumption was made. Subsequently, data will be processed through a computer program (Food Processor®) to convert the information into energy and nutrients and calculate mean intakes.

Physical Activity:

Two days prior to each trial, athletes will record the type, intensity and duration of physical activities in registration documents distributed previously.

Statistical Analysis:

Statistical analysis will be performed using the Statistical Package for Social Sciences (SPSS 18 for Windows TM®). The results will be expressed as mean ± standard deviation and it will be considered a statistically significant for p < 0.05. Normality will be assessed by the Kolmogorov-Smirnov test. Data will be analyzed by two-way repeated-measures ANOVA (treatment [two levels: MS and P-CHO supplement] vs time [five levels]) to determine whether there are any statistically significant effects of time or treatment (Bowtell, Sumners, Dyer, Fox, \& Mileva, 2011). The Mauchly sphericity test will be used to check homogeneity of covariance for all ANOVA analyses; violations of the assumption of sphericity will be correct using the Greenhouse-Geisser adjustment. Where appropriate, the effect size (ƞ2) will also be calculated.

Being tested
P-CHO supplement, Fruit Milk Shake
Keywords
exercise-induced muscle damage, nutritional recovery, nutritional supplement, natural food
Medical subject headings
Inflammation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • P-CHO supplementDietary supplement

    Also called Available in a common local market.

    In the first trial, this group will drink a protein (P)-carbohydrate (CHO) supplement and in the second trial the fruit milk shake.

  • Fruit Milk ShakeDietary supplement

    Also called Strawberry, bananas, skimmed milk

    The fruit content of the milk shake will be 100 g of strawberry and the amount of banana necessary to guaranty 0.8-1.2 g CHO • kg-1 BW • h-1.

Study groups in NCT01555775
Study groupRoleWhat they receive
P-CHO supplementExperimentalThis group will drink the P-CHO supplement in the first trial and the fruit milk shake in the second.
Receives: Dietary Supplement: P-CHO supplement
Fruit Milk SakeExperimentalThis group will drink the fruit milk shake in the first trial and the P-CHO supplement in the second.
Receives: Dietary Supplement: Fruit Milk Shake

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Maximal peak torque of the knee extensors muscles

    To monitor functional recovery

    Measured: Up to 48 h

  2. Creatine kinase

    To monitor muscle damage

    Measured: Up to 48 h

  3. Lactate dehydrogenase

    To monitor muscle damage

    Measured: Up to 48 h

  4. Interleukine-6

    To monitor the inflammatory process

    Measured: Up to 48 h

  5. Total antioxidant status

    To monitor oxidative stress

    Measured: Up to 48 h

  6. Delayed onset muscle soreness

    By a visual analogue scale, 10 cm in length. To monitor muscle soreness

    Measured: Up to 48 h

  7. Mid-thigh girth, Three other girths will be measured: 5, 15 and 25 cm above the superior border of the patella.

    To monitor the inflammatory process

    Measured: Up to 48 h

  8. Protein carbonyls

    To monitor oxidative stress

    Measured: Up to 48 h

Secondary outcomes (3)
  1. Percentage of body fat

    Measured: 1 week before the first trial

  2. Food records

    To assess energy intake (kcal)

    Measured: 2 days before each trial

  3. Physical activity records

    To assess energy expenditure (kcal)

    Measured: 2 days before each trial

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Mar 2012 (estimated)
  2. Study startMar 2012
  3. Primary completionMar 2012
  4. Study completionMay 2012

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Participant
Enrolment
13 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01555775
Sponsor's protocol ID
SFRH/BD/75276/2010
Status last verified
Jan 2013
First submitted
7 Mar 2012
Last updated
16 Jan 2013
Results posted
No
Data monitoring committee
No

Publications

  • Banerjee AK, Mandal A, Chanda D, Chakraborti S. Oxidant, antioxidant and physical exercise. Mol Cell Biochem. 2003 Nov;253(1-2):307-12. doi: 10.1023/a:1026032404105.

    PubMed 14619981
  • Battino M, Mezzetti B. Update on fruit antioxidant capacity: a key tool for Mediterranean diet. Public Health Nutr. 2006 Dec;9(8A):1099-103. doi: 10.1017/S1368980007668554.

    PubMed 17378947
  • Beelen M, Burke LM, Gibala MJ, van Loon L JC. Nutritional strategies to promote postexercise recovery. Int J Sport Nutr Exerc Metab. 2010 Dec;20(6):515-32. doi: 10.1123/ijsnem.20.6.515.

    PubMed 21116024
  • Ben-Amotz A, Levy Y. Bioavailability of a natural isomer mixture compared with synthetic all-trans beta-carotene in human serum. Am J Clin Nutr. 1996 May;63(5):729-34. doi: 10.1093/ajcn/63.5.729.

    PubMed 8615356
  • Bijur PE, Silver W, Gallagher EJ. Reliability of the visual analog scale for measurement of acute pain. Acad Emerg Med. 2001 Dec;8(12):1153-7. doi: 10.1111/j.1553-2712.2001.tb01132.x.

    PubMed 11733293
  • Bos C, Metges CC, Gaudichon C, Petzke KJ, Pueyo ME, Morens C, Everwand J, Benamouzig R, Tome D. Postprandial kinetics of dietary amino acids are the main determinant of their metabolism after soy or milk protein ingestion in humans. J Nutr. 2003 May;133(5):1308-15. doi: 10.1093/jn/133.5.1308.

    PubMed 12730415
  • Bowtell JL, Sumners DP, Dyer A, Fox P, Mileva KN. Montmorency cherry juice reduces muscle damage caused by intensive strength exercise. Med Sci Sports Exerc. 2011 Aug;43(8):1544-51. doi: 10.1249/MSS.0b013e31820e5adc.

    PubMed 21233776
  • Brancaccio P, Lippi G, Maffulli N. Biochemical markers of muscular damage. Clin Chem Lab Med. 2010 Jun;48(6):757-67. doi: 10.1515/CCLM.2010.179.

    PubMed 20518645
  • Burke LM, Castell LM, Stear SJ. BJSM reviews: A-Z of supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance Part 1. Br J Sports Med. 2009 Oct;43(10):728-9. doi: 10.1136/bjsm.2009.063941. No abstract available.

    PubMed 19808984
  • Burke LM, Castell LM, Stear SJ, Rogers PJ, Blomstrand E, Gurr S, Mitchell N, Stephens FB, Greenhaff PL. BJSM reviews: A-Z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance Part 4. Br J Sports Med. 2009 Dec;43(14):1088-90. doi: 10.1136/bjsm.2009.068643. No abstract available.

    PubMed 19955167
  • Cao G, Prior RL. Comparison of different analytical methods for assessing total antioxidant capacity of human serum. Clin Chem. 1998 Jun;44(6 Pt 1):1309-15.

    PubMed 9625058
  • Cheung K, Hume P, Maxwell L. Delayed onset muscle soreness : treatment strategies and performance factors. Sports Med. 2003;33(2):145-64. doi: 10.2165/00007256-200333020-00005.

    PubMed 12617692
  • Close GL, Ashton T, McArdle A, Maclaren DP. The emerging role of free radicals in delayed onset muscle soreness and contraction-induced muscle injury. Comp Biochem Physiol A Mol Integr Physiol. 2005 Nov;142(3):257-66. doi: 10.1016/j.cbpa.2005.08.005. Epub 2005 Sep 8.

    PubMed 16153865
  • Ebbeling CB, Clarkson PM. Exercise-induced muscle damage and adaptation. Sports Med. 1989 Apr;7(4):207-34. doi: 10.2165/00007256-198907040-00001.

    PubMed 2657962
  • Ehlenfeldt MK, Prior RL. Oxygen radical absorbance capacity (ORAC) and phenolic and anthocyanin concentrations in fruit and leaf tissues of highbush blueberry. J Agric Food Chem. 2001 May;49(5):2222-7. doi: 10.1021/jf0013656.

    PubMed 11368580

Questions about this trial

What is this clinical trial studying?

A study testing P-CHO supplement and Fruit Milk Shake in people with Muscle Damage and Inflammation, run by Universidade do Porto at 1 site in Portugal.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Jan 2013. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Portugal. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Maximal peak torque of the knee extensors muscles (time frame: Up to 48 h). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01555775, which also lists 44 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jan 2013.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in